Michel G - Search Results

1

Serological pattern of hepatitis C virus recurrence after liver transplantation.

Rehermann B, Seifert U, Tillmann HL, Michel G, Böker KH, Pichlmayr R, Manns MP. Rehermann B, et al. Among authors: michel g. J Hepatol. 1996 Jan;24(1):15-20. doi: 10.1016/s0168-8278(96)80180-2. J Hepatol. 1996. PMID: 8834019

2

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.

Rosenau J, Kreutz T, Kujawa M, Bahr MJ, Rifai K, Hooman N, Finger A, Michel G, Nashan B, Kuse ER, Klempnauer J, Tillmann HL, Manns MP. Rosenau J, et al. Among authors: michel g. J Hepatol. 2007 Apr;46(4):635-44. doi: 10.1016/j.jhep.2006.11.022. Epub 2007 Jan 25. J Hepatol. 2007. PMID: 17316869

3

Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union.

Trautwein C, Kiral G, Tillmann HL, Witteler H, Michel G, Manns MP. Trautwein C, et al. Among authors: michel g. J Med Virol. 1995 Apr;45(4):429-34. doi: 10.1002/jmv.1890450413. J Med Virol. 1995. PMID: 7666043

4

GOR-antibodies in patients with chronic liver disease and hepatocellular carcinoma.

Rehermann B, Schneider A, Michel G, Braun HB, Manns MP. Rehermann B, et al. Among authors: michel g. Z Gastroenterol. 1994 Jul;32(7):396-8. Z Gastroenterol. 1994. PMID: 7975776

5

A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.

Wiegand J, Wedemeyer H, Finger A, Heidrich B, Rosenau J, Michel G, Bock CT, Manns MP, Tillmann HL. Wiegand J, et al. Among authors: michel g. Antivir Ther. 2008;13(4):547-54. Antivir Ther. 2008. PMID: 18672533

6

Hepatitis C virus antibody secretion in vitro by peripheral blood lymphocytes.

Löhr H, Fleischer B, Michel G, Rossol S, Hess G, Meyer zum Büschenfelde KH, Manns M. Löhr H, et al. Among authors: michel g. J Hepatol. 1992 Jan;14(1):112-7. doi: 10.1016/0168-8278(92)90139-g. J Hepatol. 1992. PMID: 1310703

7

Anti-GOR and hepatitis C virus in autoimmune liver diseases.

Michel G, Ritter A, Gerken G, Meyer zum Büschenfelde KH, Decker R, Manns MP. Michel G, et al. Lancet. 1992 Feb 1;339(8788):267-9. doi: 10.1016/0140-6736(92)91332-3. Lancet. 1992. PMID: 1346282

8

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.

Durazzo M, Philipp T, Van Pelt FN, Lüttig B, Borghesio E, Michel G, Schmidt E, Loges S, Rizzetto M, Manns MP. Durazzo M, et al. Among authors: michel g. Gastroenterology. 1995 Feb;108(2):455-62. doi: 10.1016/0016-5085(95)90074-8. Gastroenterology. 1995. PMID: 7835588

9

Detection of Anti-GOR Antibodies in HCV Infection.

Manns MP, Michel G. Manns MP, et al. Among authors: michel g. Methods Mol Med. 1999;19:3-9. doi: 10.1385/0-89603-521-2:3. Methods Mol Med. 1999. PMID: 21374345

10

Anti-GOR in hepatitis D: specific association with hepatitis C virus superinfection.

Durazzo M, Michel G, Philipp T, Braun HB, Luttig B, Rizzetto M, Manns M. Durazzo M, et al. Among authors: michel g. Int J Clin Lab Res. 1994;24(4):227-9. doi: 10.1007/BF02592469. Int J Clin Lab Res. 1994. PMID: 7894050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,558 results

Search Page

Filters